Common cardiovascular issues encountered in geriatric critical care

Critical Care Clinics

Volumn 19, Issue 4, 2003, Pages 677-691

  Crispell, Kathy A ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ESMOLOL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; IBUTILIDE; INOTROPIC AGENT; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM SULFATE; METOPROLOL; NESIRITIDE; NITROPRUSSIDE SODIUM; VERAPAMIL;

AGE; AGED; AORTA BALLOON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; COMORBIDITY; CORONARY ARTERY DISEASE; DISABILITY; GERIATRICS; HEART ARRHYTHMIA; HEART FAILURE; HEART SURGERY; HUMAN; INCIDENCE; INTENSIVE CARE; PALLIATIVE THERAPY; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL RATE; SYMPTOMATOLOGY; TECHNOLOGY; TERMINAL CARE; TRANSLUMINAL CORONARY ANGIOPLASTY; VALVULAR HEART DISEASE;

EID: 0142157051     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(03)00049-6     Document Type: Review

References (39)

1. European Coronary Surgery Study (ECSS) Group. Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982;320:1173-80.
2. Coronary Artery Surgery Study (CASS) Principal Investigators and Their Associates. Myocardial infarction and mortality in the CASS randomized trial. N Engl J Med 1984;310:750-8.
3. VA Coronary Artery Bypass Surgery Cooperative Study Group. Eleven year survival in Veterans Affairs randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984;311:1333-9.
4. Randomized Intervention Treatment of Angina (RITA) Trial Participants. Coronary angioplasty vs coronary artery bypass surgery. Lancet 1993;341:573-80.
5. King SB, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kumer MH, et al. A randomized trial comparing coronary angioplasty with coronary artery bypass surgery. N Engl J Med 1994;331:1044-50.
6. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037-43.
7. Trial Participants CABRI. First year results of CABRI (Coronary Angioplasty vs Bypass Revascularization Investigation). Lancet 1995;346:1179-84.
8. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
9. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single vessel coronary artery disease. N Engl J Med 1992;326:10-6.
10. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;286:708-13.
11. GISSI The International Study Group. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990;336:71-5.
12. GUSTO Investigators. An international randomized trial comparing 4 thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
13. TIMI-3A Investigators. Early effects of tissue type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI-3A) Trial. Circulation 1993;87:38-52.
14. Moliterno DJ, Granger CB. Differences between unstable angina and acute myocardial infarction: the pathophysiological and clinical spectrum. In: Topol EJ, editor. Acute coronary syndromes. 1st edition. New York: Marcel Dekker; 1998. p. 67-104.
15. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998;97:2202-12.
16. Platelet Glycoprotein IIb/IIIa in Unstable Angina Receptor Suppression Using Integrelin Therapy (PURSUIT) Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
17. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms. (PRISM-PLUS) Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998;338:1488-97.
18. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
19. Berger AK, Schulman KA, Gersh BJ, Pirzada S, Breall JA, Johnson AE, et al. Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 1999;282:341-8.
20. White HD, Barbash GU, Califf RM, Simes RJ, Granger CB, Weaver WD, et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-1 trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 1996;94:1826-33.
21. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000;101:2239-46.
22. ACC/AHA Task Force. ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1999;34:890-911.
23. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, et al. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery bypass surgery study. Circulation 1990;82:1629-46.
24. Varmauskas E. Twelve-year follow-up of survival in the Randomized European Coronary Artery Surgery Study. N Engl J Med 1988;319:332-7.
25. Subramanian VA, Patel NU, Maini A. Surgical coroanry revascularization in geriatric patients. Am J Geriatr Cardiol 2002;11(3):169-72.
26. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 2001;87:413-9.
27. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-37.
28. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998;98:2282-9.
29. Croft JB, Giles WH, Pollard RA, Keenan NL, Casper ML, Anda RF. Heart failure survival among older adults in the United States: A poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999;159:505-10.
30. Clarkson PB, Wheeldon NM, MacFadyen RJ, Pringle SD, MacDonald TM. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 1996;93:2037-47.
31. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
32. AFFIRM. Unpublished data released at the American College of Cardiology Annual Scientific Session March 18, 2002.
33. Stroke Prevention in Atrial Fibrillation (SPAF) Group. Predictors of thromboembolism in atrial fibrillation: echocardiographic features of patients at risk. Ann Intern Med 1992;116:6-12.
34. Lauapacis A, et al. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: an analysis of pooled data from 5 randomized controlled trials. Arch Intern Med 1994;154:1449-57.
35. Multicenter Defibrillator Implantation Trial (MADIT) II. Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
36. Bernstein AD, Parsonnet V. Survey of cardiac pacing defibrillation in the United States in 1993. Am J Cardiol 1996;78:187-96.
37. ACC/AHA Task Force. ACC/AHA guidelines for implantation of cardiac pacemakers and anti-arrhythmia devices. J Am Coll Cardiol 1998;31:1175-209.
38. Aronow WS, Ahn C, Kronzon I, Gutstein H. Association of mitral annular calcium with new thromboembolic stroke at 44-month follow-up of 2,148 persons, mean age 81 years. Am J Cardiol 1990;65:1511-2.
39. Aronow WS, Ahn C, Kronzon I. Comparison of echocardiographic abnormalities in African-American, Hispanic and white men and women aged > 60 years. Am J Cardiol 2001;87:1131-3.